229 related articles for article (PubMed ID: 23065509)
21. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
22. Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma.
Bang SM; Kim YR; Cho HI; Chi HS; Seo EJ; Park CJ; Yoo SJ; Kim HC; Chun HG; Min HC; Oh BR; Kim TY; Lee JH; Lee DS
Cancer Genet Cytogenet; 2006 Jul; 168(2):124-32. PubMed ID: 16843102
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.
Bang SM; Seo JW; Park KU; Kim SJ; Kim K; Kim SH; Cho SR; Kim HC; Song J; Kim JS; Kim KH; Lee JH; Lee JJ; Shin MG; Suh C; Chi HS; Oh DY; Won JH; Kim HJ; Yoon SS; Lee DS;
Cancer Genet Cytogenet; 2010 Mar; 197(2):117-21. PubMed ID: 20193844
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact.
Krzisch D; Guedes N; Boccon-Gibod C; Baron M; Bravetti C; Davi F; Armand M; Smagghe L; Caron J; Bernard OA; Susin S; Chapiro E; Leblond V; Nguyen-Khac F; Roos-Weil D;
Am J Hematol; 2021 Dec; 96(12):1569-1579. PubMed ID: 34462944
[TBL] [Abstract][Full Text] [Related]
25. A large fraction of trisomy 12, 17p
Pepe F; Rassenti LZ; Pekarsky Y; Labanowska J; Nakamura T; Nigita G; Kipps TJ; Balatti V; Croce CM
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064090
[TBL] [Abstract][Full Text] [Related]
26. Interstitial deletion of 20q in a patient with Waldenström macroglobulinemia following chemotherapy.
Blann MM; Velagaleti GV; Morgan DL; Martinez RE; Conlin PA; Tonk VS
Cancer Genet Cytogenet; 2002 Jan; 132(2):145-8. PubMed ID: 11850077
[TBL] [Abstract][Full Text] [Related]
27.
Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
[No Abstract] [Full Text] [Related]
28. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
[TBL] [Abstract][Full Text] [Related]
30. Analysis of 6q deletion in Waldenstrom macroglobulinemia.
Chang H; Qi X; Xu W; Reader JC; Ning Y
Eur J Haematol; 2007 Sep; 79(3):244-7. PubMed ID: 17655703
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
32. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
[TBL] [Abstract][Full Text] [Related]
33. TP53 deletions but not trisomy 12 are adverse in B-cell lymphoproliferative disorders.
Shaw GR; Kronberger DL
Cancer Genet Cytogenet; 2000 Jun; 119(2):146-54. PubMed ID: 10867151
[TBL] [Abstract][Full Text] [Related]
34. Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
Johnson SA; Owen RG; Oscier DG; Leblond V; Levy V; Jaeger U; Seymour JF
Clin Lymphoma; 2005 Mar; 5(4):294-7. PubMed ID: 15794869
[TBL] [Abstract][Full Text] [Related]
35. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.
González-Gascón Y Marín I; Hernández-Sanchez M; Rodríguez-Vicente AE; Puiggros A; Collado R; Luño E; González T; Ruiz-Xivillé N; Ortega M; Gimeno E; Muñoz C; Infante MS; Delgado J; Vargas MT; González M; Bosch F; Espinet B; Hernández-Rivas JM; Hernández JÁ;
Leuk Lymphoma; 2018 Mar; 59(3):633-642. PubMed ID: 28728469
[TBL] [Abstract][Full Text] [Related]
36. "Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
Chapiro E; Lesty C; Gabillaud C; Durot E; Bouzy S; Armand M; Le Garff-Tavernier M; Bougacha N; Struski S; Bidet A; Laharanne E; Barin C; Veronese L; Prié N; Eclache V; Gaillard B; Michaux L; Lefebvre C; Gaillard JB; Terré C; Penther D; Bastard C; Nadal N; Fert-Ferrer S; Auger N; Godon C; Sutton L; Tournilhac O; Susin SA; Nguyen-Khac F;
Am J Hematol; 2018 Mar; 93(3):375-382. PubMed ID: 29194741
[TBL] [Abstract][Full Text] [Related]
37. [Waldenström's macroglobulinemia with an uncommon presentation].
Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
[TBL] [Abstract][Full Text] [Related]
38. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
Schop RF; Kuehl WM; Van Wier SA; Ahmann GJ; Price-Troska T; Bailey RJ; Jalal SM; Qi Y; Kyle RA; Greipp PR; Fonseca R
Blood; 2002 Oct; 100(8):2996-3001. PubMed ID: 12351413
[TBL] [Abstract][Full Text] [Related]
39. [Cytogenetic study of 28 cases of Waldenström's disease].
Broustet A; Hartmann L; Moulinier J; Staeffen J; Moretti G
Nouv Rev Fr Hematol; 1967; 7(6):809-26. PubMed ID: 4230371
[No Abstract] [Full Text] [Related]
40. Chromosome changes in 19 patients with Waldenström's macroglobulinemia.
Palka G; Spadano A; Geraci L; Fioritoni G; Dragani A; Calabrese G; Guanciali Franchi P; Stuppia L
Cancer Genet Cytogenet; 1987 Dec; 29(2):261-9. PubMed ID: 3119188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
